Overview
John Maclay practices practicing medicine in Glasgow, United Kingdom.
His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Chronic Obstructive Pulmonary Disease (COPD), and Empyema.
He is actively involved in clinical research, co-authoring 20 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about John D. Maclay
Is John D. Maclay a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. John D. Maclay is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does John D. Maclay participate in research or clinical trials?
Yes. John D. Maclay has published 20 articles and abstracts on conditions like Lung Cancer. You can view a list of John D. Maclay's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Obstructive Pulmonary Disease (COPD)
- EmpyemaMr. Maclay isExperienced. Learn about Empyema.
- Lung CancerMr. Maclay isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Maclay isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).